|

GPC3 and/or TGFβ targeting CAR-T cells Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Second Affiliated Hospital of Guangzhou Medical University1

Indications

  • Liver Disease1
  • T Cell1
  • GPC3 Gene Inactivation1
  • CAR1
  • Squamous Cell Lung Cancer1

Other1 trial

GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.